Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesis
Germinal center (GC) B cells feature repression of many gene enhancers to establish their characteristic transcriptome. Here we show that conditional deletion of Lsd1 in GCs significantly impaired GC formation, associated with failure to repress immune synapse genes linked to GC exit, which are also...
Saved in:
Published in | Nature immunology Vol. 20; no. 1; pp. 86 - 96 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.01.2019
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Germinal center (GC) B cells feature repression of many gene enhancers to establish their characteristic transcriptome. Here we show that conditional deletion of
Lsd1
in GCs significantly impaired GC formation, associated with failure to repress immune synapse genes linked to GC exit, which are also direct targets of the transcriptional repressor BCL6. We found that BCL6 directly binds LSD1 and recruits it primarily to intergenic and intronic enhancers. Conditional deletion of
Lsd1
suppressed GC hyperplasia caused by constitutive expression of BCL6 and significantly delayed BCL6-driven lymphomagenesis. Administration of catalytic inhibitors of LSD1 had little effect on GC formation or GC-derived lymphoma cells. Using a CRISPR-Cas9 domain screen, we found instead that the LSD1 Tower domain was critical for dependence on LSD1 in GC-derived B cells. These results indicate an essential role for LSD1 in the humoral immune response, where it modulates enhancer function by forming repression complexes with BCL6.
Germinal center B cells undergo reiterative rounds of proliferation and selection. Melnick and colleagues show that the histone demethylase LSD1 is necessary for this reiterative process via its interactions with the transcription factor BCL6. |
---|---|
Bibliography: | K.H. conceptualized the study, designed and performed the experiments, analyzed the data and wrote the manuscript. H.G, A.S.D and C.M performed bioinfomatic analyses. R.L., M.C, C.D, H.S., M.N.C.V, T.B and R.S. assisted in experiments. H.P.M. and R.G.K provided GSK-LSD1 inhibitor and technical advice regarding drug treatments. A.M.H edited the manuscript and provided technical advice with flow cytometry and IHC. G.I performed pathological evaluation of transplanted mice. S.W.L. cosupervised the study. A.M.M. conceptualized and supervised the study and wrote the manuscript. Present address: Cancer Genetics Incorporated, Rutherford, New Jersey, USA Author contributions |
ISSN: | 1529-2908 1529-2916 |
DOI: | 10.1038/s41590-018-0273-1 |